286 related articles for article (PubMed ID: 19945967)
1. Dietary-induced ERbeta upregulation counteracts intestinal neoplasia development in intact male ApcMin/+ mice.
Barone M; Tanzi S; Lofano K; Scavo MP; Pricci M; Demarinis L; Papagni S; Guido R; Maiorano E; Ingravallo G; Comelli MC; Francavilla A; Di Leo A
Carcinogenesis; 2010 Feb; 31(2):269-74. PubMed ID: 19945967
[TBL] [Abstract][Full Text] [Related]
2. Phospholipase Cepsilon promotes intestinal tumorigenesis of Apc(Min/+) mice through augmentation of inflammation and angiogenesis.
Li M; Edamatsu H; Kitazawa R; Kitazawa S; Kataoka T
Carcinogenesis; 2009 Aug; 30(8):1424-32. PubMed ID: 19458037
[TBL] [Abstract][Full Text] [Related]
3. Estrogen receptor beta deficiency enhances small intestinal tumorigenesis in ApcMin/+ mice.
Giroux V; Lemay F; Bernatchez G; Robitaille Y; Carrier JC
Int J Cancer; 2008 Jul; 123(2):303-311. PubMed ID: 18464259
[TBL] [Abstract][Full Text] [Related]
4. Liposome-mediated adenomatous polyposis coli gene therapy: a novel anti-adenoma strategy in multiple intestinal neoplasia mouse model.
Lee J; Hargest R; Wasan H; Phillips RK
Dis Colon Rectum; 2004 Dec; 47(12):2105-13. PubMed ID: 15657662
[TBL] [Abstract][Full Text] [Related]
5. Estrogen receptor beta expression and apoptosis of spermatocytes of mice overexpressing a rat androgen-binding protein transgene.
Selva DM; Tirado OM; Toràn N; Suárez-Quian CA; Reventos J; Munell F
Biol Reprod; 2004 Nov; 71(5):1461-8. PubMed ID: 15215204
[TBL] [Abstract][Full Text] [Related]
6. Methylenetetrahydrofolate reductase deficiency and low dietary folate reduce tumorigenesis in Apc min/+ mice.
Lawrance AK; Deng L; Rozen R
Gut; 2009 Jun; 58(6):805-11. PubMed ID: 19174418
[TBL] [Abstract][Full Text] [Related]
7. Reciprocal expression of ERalpha and ERbeta is associated with estrogen-mediated modulation of intestinal tumorigenesis.
Weyant MJ; Carothers AM; Mahmoud NN; Bradlow HL; Remotti H; Bilinski RT; Bertagnolli MM
Cancer Res; 2001 Mar; 61(6):2547-51. PubMed ID: 11289129
[TBL] [Abstract][Full Text] [Related]
8. Olive oil and omega-3 polyunsaturated fatty acids suppress intestinal polyp growth by modulating the apoptotic process in ApcMin/+ mice.
Barone M; Notarnicola M; Caruso MG; Scavo MP; Viggiani MT; Tutino V; Polimeno L; Pesetti B; Di Leo A; Francavilla A
Carcinogenesis; 2014 Jul; 35(7):1613-9. PubMed ID: 24632492
[TBL] [Abstract][Full Text] [Related]
9. Morphological and molecular processes of polyp formation in Apc(delta716) knockout mice.
Oshima H; Oshima M; Kobayashi M; Tsutsumi M; Taketo MM
Cancer Res; 1997 May; 57(9):1644-9. PubMed ID: 9135000
[TBL] [Abstract][Full Text] [Related]
10. The threshold level of adenomatous polyposis coli protein for mouse intestinal tumorigenesis.
Li Q; Ishikawa TO; Oshima M; Taketo MM
Cancer Res; 2005 Oct; 65(19):8622-7. PubMed ID: 16204028
[TBL] [Abstract][Full Text] [Related]
11. Resistant carbohydrates stimulate cell proliferation and crypt fission in wild-type mice and in the Apc(Min/+) mouse model of intestinal cancer, association with enhanced polyp development.
Mandir N; Englyst H; Goodlad RA
Br J Nutr; 2008 Oct; 100(4):711-21. PubMed ID: 18279550
[TBL] [Abstract][Full Text] [Related]
12. ERβ expression in normal, adenomatous and carcinomatous tissues of patients with familial adenomatous polyposis.
Barone M; Scavo MP; Papagni S; Piscitelli D; Guido R; Di Lena M; Comelli MC; Di Leo A
Scand J Gastroenterol; 2010 Nov; 45(11):1320-8. PubMed ID: 20446826
[TBL] [Abstract][Full Text] [Related]
13. Effects of dietary folate on intestinal tumorigenesis in the apcMin mouse.
Song J; Medline A; Mason JB; Gallinger S; Kim YI
Cancer Res; 2000 Oct; 60(19):5434-40. PubMed ID: 11034085
[TBL] [Abstract][Full Text] [Related]
14. Chemopreventive effect of ERβ-Selective agonist on intestinal tumorigenesis in Apc(Min/+) mice.
Giroux V; Bernatchez G; Carrier JC
Mol Carcinog; 2011 May; 50(5):359-69. PubMed ID: 21480389
[TBL] [Abstract][Full Text] [Related]
15. Wnt inhibitory factor-1: a candidate for a new player in tumorigenesis of intestinal epithelial cells.
Cebrat M; Strzadala L; Kisielow P
Cancer Lett; 2004 Mar; 206(1):107-13. PubMed ID: 15019166
[TBL] [Abstract][Full Text] [Related]
16. Modulation of tumor formation and intestinal cell migration by estrogens in the Apc(Min/+) mouse model of colorectal cancer.
Javid SH; Moran AE; Carothers AM; Redston M; Bertagnolli MM
Carcinogenesis; 2005 Mar; 26(3):587-95. PubMed ID: 15579483
[TBL] [Abstract][Full Text] [Related]
17. Plasminogen activator inhibitor-1 (Pai-1) blockers suppress intestinal polyp formation in Min mice.
Mutoh M; Niho N; Komiya M; Takahashi M; Ohtsubo R; Nakatogawa K; Ueda K; Sugimura T; Wakabayashi K
Carcinogenesis; 2008 Apr; 29(4):824-9. PubMed ID: 18258607
[TBL] [Abstract][Full Text] [Related]
18. Naringin, a natural dietary compound, prevents intestinal tumorigenesis in Apc (Min/+) mouse model.
Zhang YS; Li Y; Wang Y; Sun SY; Jiang T; Li C; Cui SX; Qu XJ
J Cancer Res Clin Oncol; 2016 May; 142(5):913-25. PubMed ID: 26702935
[TBL] [Abstract][Full Text] [Related]
19. Chemoprevention of familial adenomatous polyposis by low doses of atorvastatin and celecoxib given individually and in combination to APCMin mice.
Swamy MV; Patlolla JM; Steele VE; Kopelovich L; Reddy BS; Rao CV
Cancer Res; 2006 Jul; 66(14):7370-7. PubMed ID: 16849589
[TBL] [Abstract][Full Text] [Related]
20. Activation of nuclear hormone receptor peroxisome proliferator-activated receptor-delta accelerates intestinal adenoma growth.
Gupta RA; Wang D; Katkuri S; Wang H; Dey SK; DuBois RN
Nat Med; 2004 Mar; 10(3):245-7. PubMed ID: 14758356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
